Lactobacillus fermentum attenuates the proinflammatory effect of Yersinia enterocolitica on human epithelial cells

Inflammatory Bowel Diseases

Volumn 13, Issue 1, 2007, Pages 83-90

  Frick, Julia Stefanie ^a   Schenk, Katrin ^a   Quitadamo, Matteo ^a   Kahl, Frauke ^a   Köberle, Martin ^a   Bohn, Erwin ^a   Aepfelbacher, Martin ^b   Autenrieth, Ingo B ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

IL 8; Inflammation; Lactobacilli; Yersinia

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE C; PHOSPHOLIPID; PROBIOTIC AGENT; RAC PROTEIN;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EPITHELIUM CELL; HELA CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; LACTOBACILLUS FERMENTUM; MICROFLORA; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SUPERNATANT; YERSINIA ENTEROCOLITICA;

BACTERIAL ADHESION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ENDOPEPTIDASE K; EPITHELIAL CELLS; GLYCEROPHOSPHOLIPIDS; HELA CELLS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-8; IRON COMPOUNDS; LACTOBACILLUS FERMENTUM; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RAC1 GTP-BINDING PROTEIN; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

EID: 33846171563     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20009     Document Type: Article

References (31)

1. Ahrne S, Nobaek S, Jeppsson B, et al. The normal Lactobacillus flora of healthy human rectal and oral mucosa. J Appl Microbiol. 1998;85:88-94.
2. Molin G, Jeppsson B, Johansson ML, et al. Numerical taxonomy of Lactobacillus spp. associated with healthy and diseased mucosa of the human intestines. J Appl Bacteriol. 1993;74:314-323.
3. Hirano J, Yoshida T, Sugiyama T, et al. The effect of Lactobacillus rhamnosus on enterohemorrhagic Escherichia coli infection of human intestinal cells in vitro. Microbiol Immunol. 2003;47:405-409.
4. Pant AR, Graham SM, Allen SJ, et al. Lactobacillus GG and acute diarrhoea in young children in the tropics. J Trop Pediatr. 1996;42:162-165.
5. Vanderhoof JA, Whitney DB, Antonson DL, et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999;135:564-568.
6. Ogawa M, Shimizu K, Nomoto K, et al. Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits. Infect Immun. 2001;69:1101-1108.
7. Nader de Macias ME, Apella MC, Romero NC, et al. Inhibition of Shigella sonnei by Lactobacillus casei and Lact. acidophilus. J Appl Bacteriol. 1992;73:407-411.
8. Matsumoto S, Hara T, Hori T, et al. Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin Exp Immunol. 2005;140:417-426.
9. Zhang L, Li N, Caicedo R, et al. Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. J Nutr. 2005;135:1752-1756.
10. Tien MT, Girardin SE, Regnault B, et al. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol. 2006;176:1228-1237.
11. Kampik D, Schulte R, Autenrieth IB. Yersinia enterocolitica invasin protein triggers differential production of interleukin-1, interleukin-8, monocyte chemoattractant protein 1, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor alpha in epithelial cells: implications for understanding the early cytokine network in Yersinia infections. Infect Immun. 2000;68:2484-2492.
12. Schulte R, Zumbihl R, Kampik D, et al. Wortmannin blocks Yersinia invasin-triggered internalization, but not interleukin-8 production by epithelial cells. Med Microbiol Immunol (Berl). 1998;187:53-60.
13. Schulte R, Grassl GA, Preger S, et al. Yersinia enterocolitica invasin protein triggers IL-8 production in epithelial cells via activation of Rel p65-p65 homodimers. FASEB J. 2000;14:1471-1484.
14. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol. 1994;55:97-179.
15. Eckmann L, Kagnoff MF. Intestinal mucosal responses to microbial infection. Springer Semin Immunopathol. 2005.
16. Jung HC, Eckmann L, Yang SK, et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest. 1995;95:55-65.
17. Heesemann J, Gross U, Gruter L. Genetic manipulation of virulence of Yersinia enterocolitica. Contrib Microbiol Immunol. 1987;9:312-316.
18. Schulte R, Autenrieth IB. Yersinia enterocolitica-induced interleukin-8 secretion by human intestinal epithelial cells depends on cell differentiation. Infect Immun. 1998;66:1216-1224.
19. MacGregor GR, Caskey CT. Construction of plasmids that express E. coli beta-galactosidase in mammalian cells. Nucleic Acids Res. 1989;17:2365.
20. Sander EE, ten Klooster JP, van Delft S, et al. Rac downregulates Rhô activity, reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J Cell Biol. 1999;147:1009-1022.
21. Ruckdeschel K, Pfaffinger G, Trulzsch K, et al. The proteasome pathway destabilizes Yersinia outer protein E and represses its antihost cell activities. J Immunol. 2006;176:6093-6102.
22. Ma D, Forsythe P, Bienenstock J. Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun. 2004;72:5308-5314.
23. Rachmilewitz D, Karmeli F, Takabayashi K, et al. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology. 2002;122:1428-1441.
24. Autenrieth I, Hantke K, Heesemann J. Immunosuppression of the host and delivery of iron to the pathogen: a possible dual role of siderophores in the pathogenesis of microbial infections? Med Microbiol Immunol (Berl). 1991;180:135-141.
25. Ewald JH, Heesemann J, Rudiger H, et al. Interaction of polymorphonuclear leukocytes with Yersinia enterocolitica: role of the Yersinia virulence plasmid and modulation by the iron-chelator desferrioxamine B. J Infect Dis. 1994;170:140-150.
26. Wang PY, Kitchens RL, Munford RS. Phosphatidylinositides bind to plasma membrane CD14 and can prevent monocyte activation by bacterial lipopolysaccharide. J Biol Chem. 1998;273:24309-24313.
27. Juris SJ, Shao F, Dixon JE. Yersinia effectors target mammalian signalling pathways. Cell Microbiol. 2002;4:201-211.
28. Grassl GA, Kracht M, Wiedemann A, et al. Activation of NF-kappaB and IL-8 by Yersinia enterocolitica invasin protein is conferred by engagement of Rac1 and MAP kinase cascades. Cell Microbiol. 2003;5:957-971.
29. Rothwarf DM, Karin M. The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE. 1999;1999:RE1.
30. Malinin NL, Boldin MP, Kovalenko AV, et al. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature. 1997;385:540-544.
31. Miettinen M, Lehtonen A, Julkunen I. et al. Lactobacilli and Streptococci activate NF-kappa B and STAT signaling pathways in human macrophages. J Immunol. 2000;164:3733-3740.